- Indication
- Covid-19 (CMDU only)
- RAG rating
- Red
- Document type
- NICE technology appraisal
- Place
- Hertfordshire and West Essex ICB
- Output type
- Pharmacy / Prescribing
Nirmatrelvir plus ritonavir
Nirmatrelvir plus ritonavir (Paxlovid) is recommended for
restricted use as an option for treating COVID-19 in eligible adult groups in line
with NICE TA878.
Eligible patients reporting a positive test should be
advised to call 111 urgently for an assessment for COVID-19 treatment. They
will determine which treatment, if any, is suitable, and make any necessary
arrangements for prescribing oral treatments for dispensing at a community
pharmacy, or for a hospital referral if intravenous treatment is needed.
Information for patients is available at COVID-19
medicines (CMDU) - Herts and West Essex ICS